Little is known about the effect of recent advances, particularly the approval of venetoclax in late 2018, in acute myeloid leukemia (AML) treatment on racial/ethnic disparities in survival outcomes. Therefore, researchers performed a retrospective cohort study of patients with newly diagnosed AML using data from the Flatiron Health database, a nationwide database derived from electronic health records in which data are deidentified. Results were published in Blood Advances. ...
Advertisement
Researchers investigated whether socioeconomic status and healthcare resource availability affect OS in multiple myeloma.
SGPCRI is calling for nominations for the $1M Stephenson Global Prize and Letters of Intent for their Scholar Grants.
An expert panel details the challenges of navigating an Alzheimer's disease diagnosis.
There is a revolutionary force in medicine that has the power to transform outcomes: artificial intelligence (AI).
A panel characterizes, and discusses misunderstood aspects of Alzheimer's disease.
Researchers sought to better understand the perception of dementia risk in Black men.
Advertisement
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
Urban Health Weekly
Dr. Cedric Pulliam Shares his IBD Journey & Patient Advocacy Work
CEO of AAFP Pens Open Letter to Trump; 3-Year Medical School; Healthcare is Unaffordable; Secretary of Health RFK Jr.?
Dr. Von Nguyen on the Use of AI in Medicine.
Drs. Julie Schulz and Michael Dovidio Discuss Using Lab Values for GLP-1 Drug Coverage.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.